首页> 外文OA文献 >Flavonoid Glycosides Isolated from Unique Legume Plant Extracts as Novel Inhibitors of Xanthine Oxidase
【2h】

Flavonoid Glycosides Isolated from Unique Legume Plant Extracts as Novel Inhibitors of Xanthine Oxidase

机译:从独特的豆科植物提取物中分离出的黄酮苷作为黄嘌呤氧化酶的新型抑制剂

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Legumes and the polyphenolic compounds present in them have gained a lot of interest due to their beneficial health implications. Dietary polyphenolic compounds, especially flavonoids, exert antioxidant properties and are potent inhibitors of xanthine oxidase (XO) activity. XO is the main contributor of free radicals during exercise but it is also involved in pathogenesis of several diseases such as vascular disorders, cancer and gout. In order to discover new natural, dietary XO inhibitors, some polyphenolic fractions and pure compounds isolated from two legume plant extracts were tested for their effects on XO activity. The fractions isolated from both Vicia faba and Lotus edulis plant extracts were potent inhibitors of XO with IC50 values range from 40–135 µg/mL and 55–260 µg/mL, respectively. All the pure polyphenolic compounds inhibited XO and their Ki values ranged from 13–767 µM. Ten of the compounds followed the non competitive inhibitory model whereas one of them was a competitive inhibitor. These findings indicate that flavonoid isolates from legume plant extracts are novel, natural XO inhibitors. Their mode of action is under investigation in order to examine their potential in drug design for diseases related to overwhelming XO action.
机译:由于它们有益于健康,因此豆类及其中存在的多酚化合物引起了人们的极大兴趣。饮食中的多酚化合物,尤其是类黄酮,具有抗氧化性能,是黄嘌呤氧化酶(XO)活性的有效抑制剂。 XO是运动过程中自由基的主要来源,但它也参与多种疾病的发病机理,例如血管疾病,癌症和痛风。为了发现新的天然膳食XO抑制剂,测试了从两种豆科植物提取物中分离出的一些多酚级分和纯化合物对XO活性的影响。从蚕豆和莲花可食植物提取物中分离出的馏分是有效的XO抑制剂,IC50值分别为40–135 µg / mL和55–260 µg / mL。所有纯多酚化合物均可抑制XO,其Ki值范围为13–767 µM。其中十种化合物遵循非竞争性抑制模型,而其中一种是竞争性抑制剂。这些发现表明,从豆类植物提取物中提取的黄酮类化合物是新型的天然XO抑制剂。他们的作用方式正在研究中,以检查其在药物设计中与大量XO作用相关的疾病的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号